Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis

References

• SchneiderGSchmidt-SupprianMRadRSaurDTissue-specific tumorigenesis: context mattersNat Rev Cancer201717423925328256574
   PubMedGoogle Scholar
• AllardBLonghiMSRobsonSCStaggJThe ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targetsImmunol Rev2017276112114428258700
   PubMed Web of Science ®Google Scholar
• AndrewsLPMarciscanoAEDrakeCGVignaliDALAG3 (CD223) as a cancer immunotherapy targetImmunol Rev20172761809628258692
   PubMed Web of Science ®Google Scholar
• ZhangXYPfeifferHKThorneAWMcMahonSBUSP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2ACell Cycle20087111522152418469533
   PubMed Web of Science ®Google Scholar
• GlinskyGVBerezovskaOGlinskiiABMicroarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancerJ Clin Invest200511561503152115931389
   PubMed Web of Science ®Google Scholar
• GlinskyGVGenomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathwayCell Cycle20065111208121616760651
   PubMed Web of Science ®Google Scholar
• XuHLiuYLYangYMDongXSKnock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growthInt J Colorectal Dis2012271213021773699
   PubMedGoogle Scholar
• CaoJYanQHistone ubiquitination and deubiquitination in transcription, DNA damage response, and cancerFront Oncol201222622649782
   PubMedGoogle Scholar
• DingFBaoCTianYUSP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibitionInt J Mol Sci201416130732025547493
   PubMedGoogle Scholar
• PijnappelWWTimmersHTDubbing SAGA unveils new epigenetic crosstalkMol Cell200829215215418243109
   PubMed Web of Science ®Google Scholar
• ZhaoYLangGItoSA TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencingMol Cell20082919210118206972
   PubMedGoogle Scholar
• ColeAJClifton-BlighRMarshDJHistone H2B monoubiquitination: roles to play in human malignancyEndocr Relat Cancer2015221T19T3324891457
   PubMedGoogle Scholar
• ZhangXYVarthiMSykesSMThe putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progressionMol Cell200829110211118206973
   PubMed Web of Science ®Google Scholar
• AoNLiuYBianXFengHLiuYUbiquitin-specific peptidase 22 inhibits colon cancer cell invasion by suppressing the signal transducer and activator of transcription 3/matrix metalloproteinase 9 pathwayMol Med Rep20151222107211325902005
   PubMedGoogle Scholar
• AoNLiuYFengHUbiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1Cell Physiol Biochem20143361863187524969755
   PubMedGoogle Scholar
• TangBLiangXTangFExpression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinomaInt J Oncol20154762208221626497847
   PubMed Web of Science ®Google Scholar
• JiMShiHXieYUbiquitin specific protease 22 promotes cell proliferation and tumor growth of epithelial ovarian cancer through synergy with transforming growth factor beta1Oncol Rep201533113314025369910
   PubMedGoogle Scholar
• NingZWangALiangJUSP22 promotes the G1/S phase transition by upregulating FoxM1 expression via beta-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinomaInt J Oncol20144541594160824993031
   PubMed Web of Science ®Google Scholar
• NingJZhangJLiuWLangYXueYXuSOverexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancerEur J Histochem2012564e4623361242
   PubMed Web of Science ®Google Scholar
• DaiWYaoYZhouQSunCFUbiquitin-specific peptidase 22, a histone deubiquitinating enzyme, is a novel poor prognostic factor for salivary adenoid cystic carcinomaPLoS One201491e8714824466336
   PubMed Web of Science ®Google Scholar
• WangHLiYPChenJHPrognostic significance of USP22 as an oncogene in papillary thyroid carcinomaTumour Biol20133431635163923412977
   PubMedGoogle Scholar
• PiaoSMaJWangWIncreased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinomaOral Oncol201349879680123664741
   PubMed Web of Science ®Google Scholar
• LiuYLYangYMXuHDongXSAberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancerJ Surg Oncol2011103328328921337558
   PubMed Web of Science ®Google Scholar
• StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• LauJIoannidisJPSchmidCHQuantitative synthesis in systematic reviewsAnn Intern Med199712798208269382404
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• WangZZhuLGuoTWangYYangJDecreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinomaHum Pathol20154671006101425971547
   PubMed Web of Science ®Google Scholar
• LiJWangZLiYUSP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinomaJ Cancer Res Clin Oncol201213881291129722447106
   PubMed Web of Science ®Google Scholar
• YangDDCuiBBSunLYThe co-expression of USP22 and BMI-1 may promote cancer progression and predict therapy failure in gastric carcinomaCell Biochem Biophys201161370371021735131
   PubMed Web of Science ®Google Scholar
• LiangJXNingZGaoWUbiquitin specific protease 22 induced autophagy is correlated with poor prognosis of pancreatic cancerOncol Rep20143262726273425241857
   PubMedGoogle Scholar
• HuJYangDZhangHUSP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinomaLung Cancer201588323924525907317
   PubMed Web of Science ®Google Scholar
• LiangJZhangXXieSUbiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeuticsMed Oncol201431489924573640
   PubMed Web of Science ®Google Scholar
• ZhangYYaoLZhangXElevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancerJ Cancer Res Clin Oncol201113781245125321691749
   PubMed Web of Science ®Google Scholar
• PiaoSLiuYHuJUSP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinomaPLoS One201278e4254022880026
   PubMed Web of Science ®Google Scholar
• Melo-CardenasJZhangYZhangDDFangDUbiquitin-specific peptidase 22 functions and its involvement in diseaseOncotarget2016728448484485627057639
   PubMedGoogle Scholar
• YangMLiuYDWangYYLiuTBGeTTLouGUbiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeuticsTumour Biol201435292993423979981
   PubMedGoogle Scholar
• HuJLiuYLPiaoSLYangDDYangYMCaiLExpression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancerLung Cancer201277359359922717106
   PubMed Web of Science ®Google Scholar
• SchrecengostRSDeanJLGoodwinJFUSP22 regulates oncogenic signaling pathways to drive lethal cancer progressionCancer Res201474127228624197134
   PubMed Web of Science ®Google Scholar